AUM $9.7MER 0.68%NAV $19.34Holdings 57Inception Jun 2020
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
1.2KDividend Yield
0.46%Expense Ratio
0.68%AUM
$9.7MShares Outstanding
—ETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.30% |
| Cash & Others | 0.35% |
| Financial Services | 0.35% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 81.91% |
| Germany | 6.93% |
| United Kingdom | 5.39% |
| China | 3.60% |
| France | 0.92% |
| Japan | 0.89% |
| Other | 0.35% |
Fund Information
- Issuer
- Amplify
- Category
- Healthcare
- Types
- Healthcare
- Inception Date
- Jun 18, 2020
- Description
- The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
Similar ETFs
The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund issued by Amplify that launched on Jun 18, 2020. It currently manages $9.7M in assets under management. The fund charges an expense ratio of 0.68%. The fund holds 57 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 54.6% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ALNY | Alnylam Pharmaceuticals Inc | 11.39% | 3,957 | $1.1M |
| 2 | LH | Labcorp Holdings Inc | 7.20% | 2,978 | $674K |
| 3 | DGX | Quest Diagnostics Inc | 6.61% | 4,142 | $618K |
| 4 | BNTX | BioNTech SE | 5.01% | 5,803 | $469K |
| 5 | BIO | Bio-Rad Laboratories Inc | 4.74% | 1,363 | $443K |
| 6 | PCVX | Vaxcyte Inc | 4.52% | 5,432 | $423K |
| 7 | QDEL | QuidelOrtho Corp | 4.11% | 9,250 | $385K |
| 8 | BCRX | BioCryst Pharmaceuticals Inc | 3.70% | 45,426 | $347K |
| 9 | IMCR | Immunocore Holdings PLC | 3.67% | 9,226 | $343K |
| 10 | ZLAB | Zai Lab Ltd | 3.60% | 20,729 | $337K |
| 11 | MRNA | Moderna Inc | 3.46% | 3,819 | $324K |
| 12 | DVAX | Dynavax Technologies Corp | 3.42% | 28,811 | $320K |
| 13 | IBRX | ImmunityBio Inc | 3.14% | 64,671 | $294K |
| 14 | VIR | Vir Biotechnology Inc | 2.79% | 29,948 | $261K |
| 15 | NVAX | Novavax Inc | 2.50% | 20,141 | $234K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | — | |
| 1M | — | |
| 3M | — | |
| 6M | — | |
| YTD | — | |
| 1Y | — | |
| 3Y | -5.56% | |
| 5Y | -49.05% |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$19.16
52-Week Low
—
Current Yield
0.46%
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | GERM | Healthcare(222 ETFs) | Healthcare(24 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.68% | 0.59% | 0.48% |
| AUM | $9.7M | $1.25B | $620.6M |
| Dividend Yield | 0.46% | 3.21% | 1.61% |
| Avg Volume | 1.2K | 606.9K | 100.0K |
| Holdings | 57 | 185 | 138 |
| Performance | |||
| 1-Month Return | — | -7.69% | -7.54% |
| 6-Month Return | — | +1.84% | +2.52% |
| YTD Return | — | -4.38% | -5.12% |
| 1-Year Return | — | +11.50% | +8.61% |
Compare with Another ETF
Search for an ETF to compare with GERM: